Ensysce Biosciences (ENSC) Change in Taxes (2018 - 2020)

Ensysce Biosciences (ENSC) posted quarterly Change in Taxes of -$504237.0 for Q3 2020, down 190.81% quarter-over-quarter from $555289.0 in Q2 2020.

Ensysce Biosciences (ENSC) Change in Taxes (2018 - 2020) Analysis & Trends

Ensysce Biosciences (ENSC) has reported Change in Taxes for 3 consecutive years, with -$504237.0 the latest figure, recorded in Q3 2020.

In Q3 2020, Change in Taxes changed N/A year-over-year to -$504237.0; the TTM figure through Sep 2020 stood at $91767.0 (changed N/A YoY), while the FY2019 annual figure was $31964.0, up 979.34% from the prior year.
Change in Taxes eased to -$504237.0 in Q3 2020 per ENSC's latest filing, from $555289.0 in the prior quarter.
Across five years, Change in Taxes topped out at $555289.0 in Q2 2020 and bottomed at -$504237.0 in Q3 2020.
Historically, Change in Taxes has averaged $14869.7 across 3 years, with a median of $339.0 in 2018.
Annual changes were most pronounced in 2019 — Change in Taxes sank 59.6% — and 2020, when it surged 1737.54%.
Ensysce Biosciences' Change in Taxes stood at -$339.0 in 2018, then tumbled by 9902.95% to -$33910.0 in 2019, then sank by 1386.99% to -$504237.0 in 2020.
Business Quant data shows ENSC's Change in Taxes at -$504237.0 in Q3 2020, $555289.0 in Q2 2020, and $74625.0 in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Ensysce Biosciences	942,649.19	-3.37 Mn	-	-

Download Data